Topic Hub

Ethnicity Alendronate

3 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.

3articles

24keywords mapped

2025-01-30latest review

Explore

Ethnicity Alendronate library

Showing 3 of 3 clinical reviews.

Dosing & Monitoring2025-01-30

Fosamax (Alendronate) Dosing in Black and African Ancestry Patients: What the Evidence Actually Shows

A clinician-reviewed guide to alendronate pharmacology, fracture-trial subgroup data, and real-world dosing considerations for Black and African ancestry patients, with inline citations to primary sources.

Read clinical review

Safety2026-05-27

Fosamax (Alendronate) Safety Profile Differences in East Asian Patients

Evidence-based review of alendronate safety differences in East Asian populations, including atypical femoral fracture risk, GI tolerability, pharmacogenomic factors, and dosing considerations.

Read clinical review

Dosing & Monitoring2025-01-30

Fosamax in Hispanic / Latino Patients: Documented Efficacy Gaps, Pharmacogenomics, and Dosing Considerations

A detailed clinical review of alendronate (Fosamax) efficacy in Hispanic and Latino patients, covering ethnicity-stratified trial data, CYP pharmacogenomics, diabetes-related bone quality differences, and practical dosing guidance.

Read clinical review